Clinical Trial Update: Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial updating combination therapy of a PD-1 monoclonal antibody with an HPV vaccine for cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Neoplasms
• Cervix Cancer
• Uterine Cervical Neoplasms

Drugs mentioned

• HPV vaccine
• PD-1 monoclonal antibody

Snippet

Sponsor: Buhai Wang | Conditions: Uterine Cervical Neoplasms, Cervical Cancer | Phase 2 | Status: UNKNOWN